Progenics Pharmaceuticals Inc: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2019)
- $35.0M
- Net Income/Loss (FY2019)
- -$68.6M
- Total Assets (FY2019)
- $119.5M
- Total Equity (FY2019)
- $46.6M
- Cash Flows from Operating Activities (FY2019)
- -$74.7M
Source: Progenics Pharmaceuticals Inc 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
